Skip to main content
Log in

Costs for late-stage Parkinson's disease in Germany determined

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2016 euros

Reference

  • Kruse C, et al. Resource Utilization of Patients with Parkinson's Disease in the Late Stages of the Disease in Germany: Data from the CLaSP Study. PharmacoEconomics : 23 Mar 2021. Available from: URL: https://doi.org/10.1007/s40273-021-01011-y

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Costs for late-stage Parkinson's disease in Germany determined. PharmacoEcon Outcomes News 875, 5 (2021). https://doi.org/10.1007/s40274-021-7584-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7584-4

Navigation